ketanserin has been researched along with Weight Gain in 6 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Weight Gain: Increase in BODY WEIGHT over existing weight.
| Excerpt | Relevance | Reference |
|---|---|---|
| "SR141716A dose- and age-dependently suppressed food and water intake and body weight gain and elicited head scratching, with the most potent effects observed in P18 and P28 rats." | 7.75 | Age-dependent effects of the cannabinoid CB1 antagonist SR141716A on food intake, body weight change, and pruritus in rats. ( Lefever, TW; Rawls, SM; Walker, EA; Ward, SJ; Whiteside, GT, 2009) |
| " Further, fewer preclinical adverse events were noted with 17m compared with risperidone in assays that measured prolactin secretion and weight gain." | 3.79 | Synthesis and biological investigation of coumarin piperazine (piperidine) derivatives as potential multireceptor atypical antipsychotics. ( Chen, Y; Liu, BF; Liu, S; Liu, X; Qiu, Y; Wang, S; Xu, X; Yu, M; Zhang, G; Zhang, T; Zhao, S, 2013) |
| " Addition of eugenosedin-A to the high-fat diet resulted in less weight gain and reduced hyperglycaemia, hyperinsulinaemia and hyperlipidaemia." | 3.75 | Eugenosedin-A prevents hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a high-fat diet. ( Chen, IJ; Hsieh, SL; Kwan, AL; Lin, HL; Shen, KP; Wu, BN, 2009) |
| "SR141716A dose- and age-dependently suppressed food and water intake and body weight gain and elicited head scratching, with the most potent effects observed in P18 and P28 rats." | 3.75 | Age-dependent effects of the cannabinoid CB1 antagonist SR141716A on food intake, body weight change, and pruritus in rats. ( Lefever, TW; Rawls, SM; Walker, EA; Ward, SJ; Whiteside, GT, 2009) |
| "Current therapeutic treatment for obesity is mostly focused on preventive measures involving dietary control and physical exercises in combination with anti-obesity medications." | 1.39 | Novel pyrimidoazepine analogs as serotonin 5-HT(2A) and 5-HT(2C) receptor ligands for the treatment of obesity. ( Cho, H; Cho, YS; Choi, GD; Choi, K; Im, HY; Jang, H; Kim, CH; Kim, YJ; Ko, M; Kwon, OS; Lee, J; Pae, AN; Park, WK; Seo, YW; Tae, J; Yang, HY, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, HY | 1 |
| Tae, J | 1 |
| Seo, YW | 1 |
| Kim, YJ | 1 |
| Im, HY | 1 |
| Choi, GD | 1 |
| Cho, H | 1 |
| Park, WK | 1 |
| Kwon, OS | 1 |
| Cho, YS | 1 |
| Ko, M | 1 |
| Jang, H | 1 |
| Lee, J | 2 |
| Choi, K | 1 |
| Kim, CH | 1 |
| Pae, AN | 1 |
| Chen, Y | 1 |
| Wang, S | 1 |
| Xu, X | 1 |
| Liu, X | 1 |
| Yu, M | 1 |
| Zhao, S | 1 |
| Liu, S | 1 |
| Qiu, Y | 1 |
| Zhang, T | 1 |
| Liu, BF | 1 |
| Zhang, G | 1 |
| Rasmussen, H | 1 |
| Ebdrup, BH | 1 |
| Oranje, B | 1 |
| Pinborg, LH | 1 |
| Knudsen, GM | 1 |
| Glenthøj, B | 1 |
| Shen, KP | 1 |
| Lin, HL | 1 |
| Hsieh, SL | 1 |
| Kwan, AL | 1 |
| Chen, IJ | 1 |
| Wu, BN | 1 |
| Ward, SJ | 1 |
| Lefever, TW | 1 |
| Rawls, SM | 1 |
| Whiteside, GT | 1 |
| Walker, EA | 1 |
| Pranzatelli, MR | 1 |
6 other studies available for ketanserin and Weight Gain
| Article | Year |
|---|---|
Novel pyrimidoazepine analogs as serotonin 5-HT(2A) and 5-HT(2C) receptor ligands for the treatment of obesity.
Topics: Animals; Anti-Obesity Agents; Area Under Curve; Azepines; Binding, Competitive; Dose-Response Relati | 2013 |
Synthesis and biological investigation of coumarin piperazine (piperidine) derivatives as potential multireceptor atypical antipsychotics.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Biological Availability; Coumarins; ERG1 Potassiu | 2013 |
Neocortical serotonin2A receptor binding predicts quetiapine associated weight gain in antipsychotic-naive first-episode schizophrenia patients.
Topics: Adult; Antipsychotic Agents; Body Mass Index; Dibenzothiazepines; Female; Follow-Up Studies; Humans; | 2014 |
Eugenosedin-A prevents hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a high-fat diet.
Topics: Adipose Tissue; Animals; Atorvastatin; Blood Glucose; Body Weight; Brain; Dietary Fats; Female; Glut | 2009 |
Age-dependent effects of the cannabinoid CB1 antagonist SR141716A on food intake, body weight change, and pruritus in rats.
Topics: Age Factors; Animals; Brain; Dose-Response Relationship, Drug; Drinking; Eating; Feeding Behavior; K | 2009 |
In vivo and in vitro effects of adrenocorticotrophic hormone on serotonin receptors in neonatal rat brain.
Topics: Adrenocorticotropic Hormone; Animals; Animals, Newborn; Brain Chemistry; Hydroxyindoleacetic Acid; K | 1989 |